T 100 (Tarceva 100 mg)
Generic Name: erlotinib
Pill with imprint T 100 is White, Round and has been identified as Tarceva 100 mg. It is supplied by Genentech.
Tarceva is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for T 100
Tarceva
- Generic Name:
- erlotinib
- Imprint:
- T 100
- Strength:
- 100 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- EGFR inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Genentech
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 54868-5474 | Physicians Total Care Inc. (repackager) |
More about Tarceva (erlotinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 37 Reviews – Add your own review/rating
- Drug class: EGFR inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
